Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sarel

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Enantiomer|January 1, 1996
Emanuel Gil-Av (Zimkin)S Sarel, S Weinstein
The Journal of Organic Chemistry|October 6, 1972
Synthetic and mass spectral study of bis ritter adducts from some dienoic fatty acidsS Blum, S Sarel
The Journal of Organic Chemistry|January 12, 1973
A total stereoselective synthesis of myo-, allo, neo-, and epi-inositolsC R Kowarski, S Sarel
Archiv Der Pharmazie|April 1, 1979
Syntheses of some norcholanylisoquinoline derivativesY Golander, E Breuer, S Sarel
Archiv Der Pharmazie|March 1, 1979
Synthesis of some 2'-(3-oxopregn-4-en-20-yl)oxazolidines and -thiazolidinesY Golander, E Breuer, S Sarel
Biochemical Pharmacology|June 30, 2000
Inhibition of in vitro lymphoproliferation by three novel iron chelators of the pyridoxal and salicyl aldehyde hydrazone classesD van Reyk, S Sarel, N Hunt
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Growth inhibition of drug-resistant species of Plasmodium falciparum by domain structured N1,N2-derivatized hydrazines: denticity effects, redox switches, and reductant-driven redox-cyclingS Sarel, E N Iheanacho, S Avramovici-Grisaru
International Journal of Immunopharmacology|July 1, 1992
In vitro effects of three iron chelators on mitogen-activated lymphocytes: identification of differences in their mechanisms of actionD M van Reyk, S Sarel, N H Hunt
Journal of Medicinal Chemistry|February 2, 1999
Domain-structured N1,N2-derivatized hydrazines as inhibitors of ribonucleoside diphosphate reductase: redox-cycling considerationsS Sarel, C Fizames, F Lavelle, et al.
Journal of Medicinal Chemistry|February 1, 1983
Syntheses of iron bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivativesS Avramovici-Grisaru, S Sarel, G Link, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Enantiomer|January 1, 1996
Emanuel Gil-Av (Zimkin)S Sarel, S Weinstein
The Journal of Organic Chemistry|October 6, 1972
Synthetic and mass spectral study of bis ritter adducts from some dienoic fatty acidsS Blum, S Sarel
The Journal of Organic Chemistry|January 12, 1973
A total stereoselective synthesis of myo-, allo, neo-, and epi-inositolsC R Kowarski, S Sarel
Archiv Der Pharmazie|April 1, 1979
Syntheses of some norcholanylisoquinoline derivativesY Golander, E Breuer, S Sarel
Archiv Der Pharmazie|March 1, 1979
Synthesis of some 2'-(3-oxopregn-4-en-20-yl)oxazolidines and -thiazolidinesY Golander, E Breuer, S Sarel
Biochemical Pharmacology|June 30, 2000
Inhibition of in vitro lymphoproliferation by three novel iron chelators of the pyridoxal and salicyl aldehyde hydrazone classesD van Reyk, S Sarel, N Hunt
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Growth inhibition of drug-resistant species of Plasmodium falciparum by domain structured N1,N2-derivatized hydrazines: denticity effects, redox switches, and reductant-driven redox-cyclingS Sarel, E N Iheanacho, S Avramovici-Grisaru
International Journal of Immunopharmacology|July 1, 1992
In vitro effects of three iron chelators on mitogen-activated lymphocytes: identification of differences in their mechanisms of actionD M van Reyk, S Sarel, N H Hunt
Journal of Medicinal Chemistry|February 2, 1999
Domain-structured N1,N2-derivatized hydrazines as inhibitors of ribonucleoside diphosphate reductase: redox-cycling considerationsS Sarel, C Fizames, F Lavelle, et al.
Journal of Medicinal Chemistry|February 1, 1983
Syntheses of iron bis(pyridoxal isonicotinoylhydrazone)s and the in vivo iron-removal properties of some pyridoxal derivativesS Avramovici-Grisaru, S Sarel, G Link, et al.
Pageof 2